Trial Site News
banner
trialsitenews.bsky.social
Trial Site News
@trialsitenews.bsky.social
TrialSite News is the only #digital media dedicated 100% to transparent and open coverage of medical research and developments from around the globe. #realnews
Reassessing COVID-19 Origins: Lab Leak Gains Ground, but Alternatives Persist, Is there a Cover-up? www.trialsitenews.com/a/reassessin...
Reassessing COVID-19 Origins: Lab Leak Gains Ground, but Alternatives Persist, Is there a Cover-up?
The New York Times reports a shift in the C.I.A.’s stance on the origins of COVID-19, with analysts now favoring the lab leak hypothesis. This pivot, led by newly appointed Director John Ratclif...
www.trialsitenews.com
January 25, 2025 at 11:44 PM
www.trialsitenews.com/a/fdas-remov... FDA's Removal of Diversity Guidelines Raises Concerns for Clinical Trial Equity
TrialSiteNews | Independent Censorship-Free Media for Health & Biomedical Research
Transparent coverage of clinical research
www.trialsitenews.com
January 25, 2025 at 11:41 PM
Trial Against Merck for Injuries Associated with Gardasil, HPV Vaccine Commences in Los Angeles www.trialsitenews.com/a/trial-agai...
Trial Against Merck for Injuries Associated with Gardasil, HPV Vaccine Commences in Los Angeles
 A trial began on January 22, 2025, in Los Angeles, where a woman is suing Merck, alleging that the Gardasil HPV vaccine caused her to develop an autoimmune disorder, postural orthostatic tachyca...
www.trialsitenews.com
January 24, 2025 at 10:41 PM
Merck Inks Deal with Chinese Biotech for Anti-PD-1/VEGF Bispecific Antibody--$588m Upfront & Up to $2.7b www.trialsitenews.com/a/merck-inks...
Merck Inks Deal with Chinese Biotech for Anti-PD-1/VEGF Bispecific Antibody--$588m Upfront & Up to $2.7b
Merck (NYSE: MRK) has finalized a major global license agreement with Shanghai, China-based LaNova Medicines Ltd. for LM-299, a novel investigational bispecific antibody targeting both programmed cell...
www.trialsitenews.com
January 23, 2025 at 9:41 PM
Trump to Big Pharma on Day One--Reverses Drug Pricing & Sparks Outrage Amid U.S. Healthcare Crisis www.trialsitenews.com/a/trump-to-b...
Trump to Big Pharma on Day One--Reverses Drug Pricing & Sparks Outrage Amid U.S. Healthcare Crisis
In a stunning Day-One move, President Donald Trump signed an executive order rescinding a Biden-era directive aimed at lowering prescription drug costs, leaving Americans questioning the administratio...
www.trialsitenews.com
January 23, 2025 at 9:37 PM
Senate to Hold Nomination Hearing for Robert F. Kennedy Jr. as HHS Secretary: Starts January 29, 2025 www.trialsitenews.com/a/senate-to-...
Senate to Hold Nomination Hearing for Robert F. Kennedy Jr. as HHS Secretary: Starts January 29, 2025
On January 29, 2025, the U.S. Senate Finance Committee, led by Chairman Mike Crapo (R-Idaho), will convene a hearing to consider Robert F. Kennedy (RFK) Jr.'s nomination as Secretary of the Department...
www.trialsitenews.com
January 23, 2025 at 12:05 PM
Antibody Responses to mRNA COVID-19 Vax in Nursing Home Residents—Significant Waning Starting Week #2 www.trialsitenews.com/a/antibody-r...
Antibody Responses to mRNA COVID-19 Vax in Nursing Home Residents—Significant Waning Starting Week #2
The study, spearheaded by clinical research coordinator Dr. Alexandra N. Paxitzis, Jürgen Bosch, Ph.D., and the team at Case Western Reserve, University School of Medicine and collaborators evalu...
www.trialsitenews.com
January 22, 2025 at 3:37 PM
Angelique Herbert: Acting Deputy Commissioners for Operations and Chief Operating Officer - Office of Operations, FDA www.trialsitenews.com/a/angelique-...
Angelique Herbert: Acting Deputy Commissioners for Operations and Chief Operating Officer - Office of Operations, FDA
Angelique A. Hebert currently serves as the Acting Deputy Commissioner for Operations and Chief Operating Officer of the U.S. Food and Drug Administration (FDA), bringing over 25 years of federal mana...
www.trialsitenews.com
January 21, 2025 at 9:07 PM